Short stature and microcephaly in two siblings due to a novel de novo IGF1R variant

Por Alexandra Gkourogianni, Ingrid Alvarez, Sigrun Hallgrimsdottir, Anna Ek, Ola Nilsson
Publicado em 2020-10-01

Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor

Por Mikael Montelius, Johan Spetz, Oscar Jalnefjord, Evelin Berger, Ola Nilsson, Maria Ljungberg, Eva Forssell-Aronsson
Publicado em 2018-04-01

The microRNA-processing enzyme Dicer is essential for thyroid function.

Por Daniela Frezzetti, Carla Reale, Gaetano Calì, Lucio Nitsch, Henrik Fagman, Ola Nilsson, Marzia Scarfò, Gabriella De Vita, Roberto Di Lauro
Publicado em 2011-01-01

Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice

Por Johan Spetz, Britta Langen, Nils-Petter Rudqvist, Toshima Z. Parris, Emman Shubbar, Johanna Dalmo, Bo Wängberg, Ola Nilsson, Khalil Helou, Eva Forssell-Aronsson
Publicado em 2019-03-01

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Por Signe Sparre Beck-Nielsen, Zulf Mughal, Dieter Haffner, Ola Nilsson, Elena Levtchenko, Gema Ariceta, Carmen de Lucas Collantes, Dirk Schnabel, Ravi Jandhyala, Outi Mäkitie
Publicado em 2019-02-01

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

Por Raja Padidela, Ola Nilsson, Outi Makitie, Signe Beck-Nielsen, Gema Ariceta, Dirk Schnabel, Maria Luisa Brandi, Annemieke Boot, Elena Levtchenko, Michael Smyth, Ravi Jandhyala, Zulf Mughal
Publicado em 2020-06-01